Pluristem Therapeutic (PSTI)

Add to Watchlists
Create an Alert
3.71 +0.23  +6.61% NASDAQ Apr 22, 8:00PM BATS Real time Currency in USD
View Full Chart
PSTI Price Chart
View All Events

PSTI Events

Date Type Description
May 21 Misc AGM Event for Pluristem Therapeutics Inc
View All Performance Charts

PSTI Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Pluristem Therapeutic is up 24.08% over the last year vs S&P 500 Total Return up 22.85%, United Therapeutics up 56.85%, and Actelion up 69.21%.

Get Quote for

Portfolio Strategies Featuring PSTI

Did Pluristem Therapeutic make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

PSTI Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: Israel
  • Headquarters State/Province: N/A
  • Incorporation Country: United States
  • Incorporation State/Province: Nevada
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: June 30, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Pluristem Therapeutic is a bio-therapeutics Company dedicated to the commercialization of non-personalized cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders.

Recent Quotes

Symbol Price Chg Chg % Market Cap
PSTI 3.71 +0.23 +6.61% 239.88M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.